N. Marina, M. Gebhardt, L. Teot, and R. Gorlick, Biology and Therapeutic Advances for Pediatric Osteosarcoma, The Oncologist, vol.9, issue.4, pp.422-441, 2004.
DOI : 10.1634/theoncologist.9-4-422
URL : http://theoncologist.alphamedpress.org/content/9/4/422.full.pdf

P. Picci, Osteosarcoma (osteogenic sarcoma), Orphanet J. Rare Dis, vol.2, issue.6, 2007.

A. Luetke, P. A. Meyers, I. Lewis, and H. Juergens, Osteosarcoma treatment ??? Where do we stand? A state of the art review, Cancer Treatment Reviews, vol.40, issue.4, pp.40-523, 2014.
DOI : 10.1016/j.ctrv.2013.11.006

D. Donati, M. Colangeli, S. Colangeli, C. D. Bella, and M. Mercuri, Allograft-Prosthetic Composite in the Proximal Tibia After Bone Tumor Resection, Clinical Orthopaedics and Related Research, vol.466, issue.2, pp.466-459, 2008.
DOI : 10.1007/s11999-007-0055-9

P. Hernigou, G. Delepine, D. Goutallier, and A. Julieron, Massive allografts sterilised by irradiation. Clinical results, The Journal of Bone and Joint Surgery. British volume, vol.75, issue.6, pp.75-904, 1993.
DOI : 10.1302/0301-620X.75B6.8245080

M. P. Bus, P. D. Dijkstra, M. A. Van-de-sande, A. H. Taminiau, H. W. Schreuder et al., Intercalary Allograft Reconstructions Following Resection of Primary Bone Tumors, The Journal of Bone & Joint Surgery, vol.96, issue.4, pp.96-122, 2014.
DOI : 10.2106/JBJS.M.00655

P. H. Hilven, L. Bayliss, T. Cosker, P. D. Dijkstra, P. C. Jutte et al., The vascularised fibular graft for limb salvage after bone tumour surgery, The Bone & Joint Journal, vol.97, issue.6, pp.97-853, 2015.
DOI : 10.1302/0301-620X.97B6.34692

M. N. Zimel, A. M. Cizik, T. B. Rapp, J. S. Weisstein, and E. , Conrad 3rd, Megaprosthesis versus Condyle-sparing intercalary allograft: distal femoral sarcoma, Clin. Orthop. Relat. Res, pp.467-2813, 2009.

S. S. Bielack, B. Kempf-bielack, G. Delling, G. U. Exner, S. Flege et al., Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols, Journal of Clinical Oncology, vol.20, issue.3, pp.776-790, 2002.
DOI : 10.1200/JCO.2002.20.3.776

M. A. Brennan, A. Renaud, J. Amiaud, M. T. Rojewski, H. Schrezenmeier et al., Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate, Stem Cell Research & Therapy, vol.5, issue.5, 2014.
DOI : 10.1016/j.biomaterials.2014.08.018
URL : https://hal.archives-ouvertes.fr/inserm-01205389

S. Ferrari, G. Bacci, P. Picci, M. Mercuri, A. Briccoli et al., Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy*, Annals of Oncology, vol.8, issue.8, pp.765-771, 1997.
DOI : 10.1023/A:1008221713505

A. L. Gamblin, M. A. Brennan, A. Renaud, H. Yagita, F. Lezot et al., Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: The local implication of osteoclasts and macrophages, Biomaterials, vol.35, issue.36, pp.9660-9667, 2014.
DOI : 10.1016/j.biomaterials.2014.08.018

P. A. Meyers, G. Heller, J. Healey, A. Huvos, J. Lane et al., Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience., Journal of Clinical Oncology, vol.10, issue.1, pp.5-15, 1992.
DOI : 10.1200/JCO.1992.10.1.5

G. Grisendi, C. Spano, N. D. Souza, V. Rasini, E. Veronesi et al., Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas, STEM CELLS, vol.94, issue.3, pp.33-859, 2015.
DOI : 10.1038/sj.bjc.6603092

A. Mohr, M. Lyons, L. Deedigan, T. Harte, G. Shaw et al., Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model, Journal of Cellular and Molecular Medicine, vol.18, issue.6b, pp.12-2628, 2008.
DOI : 10.1089/hum.2007.034

G. Grisendi, R. Bussolari, E. Veronesi, S. Piccinno, J. S. Burns et al., Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers, Am. J. Cancer Res, vol.1, pp.787-805, 2011.

P. A. Zuk, M. Zhu, P. Ashjian, D. A. De-ugarte, J. I. Huang et al., Human Adipose Tissue Is a Source of Multipotent Stem Cells, Molecular Biology of the Cell, vol.7, issue.12, pp.13-4279, 2002.
DOI : 10.1089/107632701300062859

F. Lu, J. Li, J. Gao, R. Ogawa, C. Ou et al., Improvement of the Survival of Human Autologous Fat Transplantation by Using VEGF-Transfected Adipose-Derived Stem Cells, Plastic and Reconstructive Surgery, vol.124, issue.5, pp.1437-1446, 2009.
DOI : 10.1097/PRS.0b013e3181babbb6

K. Yoshimura, K. Sato, N. Aoi, M. Kurita, T. Hirohi et al., Cell-Assisted Lipotransfer for Cosmetic Breast Augmentation: Supportive Use of Adipose-Derived Stem/Stromal Cells, Aesthetic Plastic Surgery, vol.7, issue.3 Suppl, pp.32-48, 2008.
DOI : 10.1007/s00266-007-9019-4

A. Sterodimas, J. De-faria, B. Nicaretta, and F. Boriani, Autologous Fat Transplantation Versus Adipose-Derived Stem Cell???Enriched Lipografts: A Study, Aesthetic Surgery Journal, vol.63, issue.2, pp.31-682, 2011.
DOI : 10.1016/j.bjps.2009.07.018
URL : https://academic.oup.com/asj/article-pdf/31/6/682/17881352/31-6-682.pdf

R. Perez-cano, J. J. Vranckx, J. M. Lasso, C. Calabrese, B. Merck et al., Prospective trial of Adipose-Derived Regenerative Cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial, European Journal of Surgical Oncology (EJSO), vol.38, issue.5, pp.38-382, 2012.
DOI : 10.1016/j.ejso.2012.02.178

S. F. Trojahn-kolle, R. S. Oliveri, P. V. Glovinski, J. J. Elberg, A. Fischer-nielsen et al., Importance of mesenchymal stem cells in autologous fat grafting: A systematic review of existing studies, Journal of Plastic Surgery and Hand Surgery, vol.51, issue.8, pp.59-68, 2012.
DOI : 10.1016/j.anplas.2005.10.001

Z. Yingbo and Y. Daping, Supplementation of Fat Grafts With Adipose-Derived Regenerative Cells Improves Long-Term Graft Retention, Annals of Plastic Surgery, vol.68, issue.1, p.68, 2012.
DOI : 10.1097/SAP.0b013e31822d9e04

W. K. Hsu, J. C. Wang, N. Q. Liu, L. Krenek, P. A. Zuk et al., Stem Cells from Human Fat as Cellular Delivery Vehicles in an Athymic Rat Posterolateral Spine Fusion Model, The Journal of Bone and Joint Surgery-American Volume, vol.90, issue.5, pp.90-1043, 2008.
DOI : 10.2106/JBJS.G.00292

J. S. Burns, A. Safwat, G. Grisendi, M. Kassem, and M. Dominici, Sarcomas as a mise en abyme of mesenchymal stem cells: Exploiting interrelationships for cell mediated anticancer therapy, Cancer Letters, vol.325, issue.1, pp.325-326, 2012.
DOI : 10.1016/j.canlet.2012.05.027

A. H. Klopp, A. Gupta, E. Spaeth, M. Andreeff, and F. Marini-3rd, Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?, STEM CELLS, vol.124, issue.1, pp.11-19, 2011.
DOI : 10.1002/ijc.23939

Z. Y. Bian, Q. M. Fan, G. Li, W. T. Xu, and T. T. Tang, Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2, Cancer Sci, pp.2554-2560, 2010.

S. Tsukamoto, K. Honoki, H. Fujii, Y. Tohma, A. Kido et al., Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model, Int. J. Oncol, pp.40-163, 2012.

W. T. Xu, Z. Y. Bian, Q. M. Fan, G. Li, and T. T. Tang, Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis, Cancer Letters, vol.281, issue.1, pp.281-313, 2009.
DOI : 10.1016/j.canlet.2009.02.022

P. Perrot, J. Rousseau, A. L. Bouffaut, F. Redini, E. Cassagnau et al., Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence, PLoS ONE, vol.17, issue.6, p.10999, 2010.
DOI : 10.1371/journal.pone.0010999.s001
URL : https://hal.archives-ouvertes.fr/inserm-00667931

L. Endo-munoz, A. Cumming, D. Rickwood, D. Wilson, C. Cueva et al., Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases, Cancer Research, vol.70, issue.18, pp.7063-7072, 2010.
DOI : 10.1158/0008-5472.CAN-09-4291

L. Endo-munoz, A. Evdokiou, and N. A. Saunders, The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1826, issue.2, pp.2012-434, 1826.
DOI : 10.1016/j.bbcan.2012.07.003

D. Heymann, B. Ory, F. Blanchard, M. F. Heymann, P. Coipeau et al., Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma, Bone, vol.37, issue.1, pp.74-86, 2005.
DOI : 10.1016/j.bone.2005.02.020

J. Rousseau, V. Escriou, P. Perrot, G. Picarda, C. Charrier et al., Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models, Cancer Gene Therapy, vol.8, issue.6, pp.387-397, 2010.
DOI : 10.1002/jcb.21556

S. R. Coleman, Long-Term survival of fat transplants: Controlled demonstrations, Aesthetic Plastic Surgery, vol.78, issue.5, pp.421-425, 1995.
DOI : 10.1007/BF00453875

P. Covarrubias, L. Cardenas-camarena, J. Guerrerosantos, L. Valenzuela, I. Espejo et al., Evaluation of the histologic changes in the fatgrafted facial skin: clinical trial, Aesthetic Plast. Surg, pp.37-778, 2013.

E. Delay, S. Garson, G. Tousson, and R. Sinna, Fat Injection to the Breast: Technique, Results, and Indications Based on 880 Procedures Over 10 Years, Aesthetic Surgery Journal, vol.29, issue.5, pp.29-360, 2009.
DOI : 10.1016/j.asj.2009.08.010

T. Cordonnier, A. Langonne, J. Sohier, P. Layrolle, P. Rosset et al., Consistent Osteoblastic Differentiation of Human Mesenchymal Stem Cells with Bone Morphogenetic Protein 4 and Low Serum, Tissue Engineering Part C: Methods, vol.17, issue.3, pp.249-259, 2011.
DOI : 10.1089/ten.tec.2010.0387

M. A. Brennan, A. Renaud, A. L. Gamblin, C. D-'arros, S. Nedellec et al., 3D cell culture and osteogenic differentiation of human bone marrow stromal cells plated onto jet-sprayed or electrospun micro-fiber scaffolds, Biomedical Materials, vol.10, issue.4, p.45019, 2015.
DOI : 10.1088/1748-6041/10/4/045019

L. Duplomb, M. Baud-'huin, C. Charrier, M. Berreur, V. Trichet et al., Phosphorylation of Signal Transducer and Activator of Transcription 3, Endocrinology, vol.149, issue.7, pp.3688-3697, 2008.
DOI : 10.1210/en.2007-1719
URL : https://hal.archives-ouvertes.fr/inserm-00667501

S. Chevalier, M. Fourcin, O. Robledo, J. Wijdenes, A. Pouplard-barthelaix et al., Interleukin-6 Family of Cytokines Induced Activation of Different Functional Sites Expressed by gp130 Transducing Protein, Journal of Biological Chemistry, vol.81, issue.25, pp.271-14764, 1996.
DOI : 10.1126/science.1542792

B. Gobin, G. Moriceau, B. Ory, C. Charrier, R. Brion et al., Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models, PLoS ONE, vol.22, issue.3, p.90795, 2014.
DOI : 10.1371/journal.pone.0090795.s004

K. J. Livak and T. D. Schmittgen, Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2???????CT Method, Methods, vol.25, issue.4, pp.402-408, 2001.
DOI : 10.1006/meth.2001.1262

M. Dominici, K. L. Blanc, I. Mueller, I. Slaper-cortenbach, F. Marini et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, The International Society for Cellular Therapy position statement, pp.315-317, 2006.
DOI : 10.1080/14653240600855905

J. Rousseau, V. Escriou, F. Lamoureux, R. Brion, J. Chesneau et al., Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models, Journal of Bone and Mineral Research, vol.390, issue.10, pp.26-2452, 2011.
DOI : 10.1016/j.bbrc.2009.10.020

C. P. Gibbs, V. G. Kukekov, J. D. Reith, O. Tchigrinova, O. N. Suslov et al., Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis, Neoplasia, vol.7, issue.11, pp.967-976, 2005.
DOI : 10.1593/neo.05394

H. Wilson, M. Huelsmeyer, R. Chun, K. M. Young, K. Friedrichs et al., Isolation and characterisation of cancer stem cells from canine osteosarcoma, The Veterinary Journal, vol.175, issue.1, pp.69-75, 2008.
DOI : 10.1016/j.tvjl.2007.07.025

P. P. Levings, S. V. Mcgarry, T. P. Currie, D. M. Nickerson, S. Mcclellan et al., Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in Osteosarcoma, Cancer Research, vol.69, issue.14, pp.69-5648, 2009.
DOI : 10.1158/0008-5472.CAN-08-3580

L. Bochet, C. Lehuede, S. Dauvillier, Y. Y. Wang, B. Dirat et al., Adipocyte-Derived Fibroblasts Promote Tumor Progression and Contribute to the Desmoplastic Reaction in Breast Cancer, Cancer Research, vol.73, issue.18, pp.73-5657, 2013.
DOI : 10.1158/0008-5472.CAN-13-0530

A. Carriere, T. G. Ebrahimian, S. Dehez, N. Auge, C. Joffre et al., Preconditioning by Mitochondrial Reactive Oxygen Species Improves the Proangiogenic Potential of Adipose-Derived Cells-Based Therapy, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.7, pp.29-1093, 2009.
DOI : 10.1161/ATVBAHA.109.188318
URL : https://hal.archives-ouvertes.fr/hal-00461349

J. Rehman, D. Traktuev, J. Li, S. Merfeld-clauss, C. J. Temm-grove et al., Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells, Circulation, vol.109, issue.10, pp.1292-1298, 2004.
DOI : 10.1161/01.CIR.0000121425.42966.F1

T. Shimizu, T. Ishikawa, S. Iwai, A. Ueki, E. Sugihara et al., Fibroblast Growth Factor-2 Is an Important Factor that Maintains Cellular Immaturity and Contributes to Aggressiveness of Osteosarcoma, Molecular Cancer Research, vol.10, issue.3, pp.10-454, 2012.
DOI : 10.1158/1541-7786.MCR-11-0347

E. R. Motrescu, S. Blaise, N. Etique, N. Messaddeq, M. P. Chenard et al., Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions, Oncogene, vol.269, issue.49, pp.6347-6355, 2008.
DOI : 10.1038/ncpendmet0456
URL : https://hal.archives-ouvertes.fr/inserm-00350819

M. David, E. Wannecq, F. Descotes, S. Jansen, B. Deux et al., Cancer Cell Expression of Autotaxin Controls Bone Metastasis Formation in Mouse through Lysophosphatidic Acid-Dependent Activation of Osteoclasts, PLoS ONE, vol.5, issue.3, p.9741, 2010.
DOI : 10.1371/journal.pone.0009741.t001

B. Dirat, L. Bochet, M. Dabek, D. Daviaud, S. Dauvillier et al., Cancerassociated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion, Cancer Res, pp.71-2455, 2011.
DOI : 10.1158/0008-5472.can-10-3323
URL : https://hal.archives-ouvertes.fr/inserm-00819288

K. V. Nguyen-ngoc, K. J. Cheung, A. Brenot, E. R. Shamir, R. S. Gray et al., ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium, Proc. Natl. Acad
DOI : 10.1016/j.yexcr.2004.08.037
URL : http://www.pnas.org/content/109/39/E2595.full.pdf

P. Zhang, L. Dong, K. Yan, H. Long, T. T. Yang et al., CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF, Oncology Reports, vol.30, issue.4, pp.30-1753, 2013.
DOI : 10.3892/or.2013.2619

F. Lamoureux, P. Richard, Y. Wittrant, S. Battaglia, P. Pilet et al., Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption, Cancer Research, vol.67, issue.15, pp.67-7308, 2007.
DOI : 10.1158/0008-5472.CAN-06-4130

R. S. Waterman, S. L. Henkle, and A. M. Betancourt, Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth Whereas MSC2-Treatment Promotes Tumor Growth and Metastasis, PLoS ONE, vol.7, issue.9, p.45590, 2012.
DOI : 10.1371/journal.pone.0045590.s004
URL : https://doi.org/10.1371/journal.pone.0045590

M. E. Aanstoos, D. P. Regan, R. J. Rose, L. S. Chubb, and N. P. Ehrhart, Do Mesenchymal Stromal Cells Influence Microscopic Residual or Metastatic Osteosarcoma in a Murine Model?, Clinical Orthopaedics and Related Research??, vol.474, issue.3, pp.11999-12014, 2015.
DOI : 10.1007/s11999-015-4362-2

P. Hernigou, Y. Homma, C. H. Flouzat-lachaniette, A. Poignard, N. Chevallier et al., Cancer Risk Is Not Increased in Patients Treated for Orthopaedic Diseases with Autologous Bone Marrow Cell Concentrate, The Journal of Bone and Joint Surgery-American Volume, vol.95, issue.24, pp.95-2215, 2013.
DOI : 10.2106/JBJS.M.00261

C. J. Centeno, J. R. Schultz, M. Cheever, M. Freeman, S. Faulkner et al., Safety and Complications Reporting Update on the Re-Implantation of Culture-Expanded Mesenchymal Stem Cells Using Autologous Platelet Lysate Technique, Current Stem Cell Research & Therapy, vol.6, issue.4, pp.368-378, 2011.
DOI : 10.2174/157488811797904371

P. Hernigou, C. H. Flouzat-lachaniette, J. Delambre, N. Chevallier, and H. Rouard, Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?, International Orthopaedics, vol.281, issue.6, pp.38-1825, 2014.
DOI : 10.1016/j.canlet.2009.02.022

P. Avril, F. Duteille, P. Ridel, M. F. Heymann, G. De-pinieux et al., Opposite Effects of Soluble Factors Secreted by Adipose Tissue on Proliferating and Quiescent Osteosarcoma Cells, Plastic and Reconstructive Surgery, vol.137, issue.3, 2015.
DOI : 10.1097/01.prs.0000479989.88114.8b
URL : https://hal.archives-ouvertes.fr/inserm-01792101